Clinical Trial News and Research

RSS

MIT radar technology fights breast cancer

Treating breast cancer with a type of heat therapy derived from MIT radar research can significantly increase the effectiveness of chemotherapy, according to results from the fourth clinical trial of the technique reported online Nov. 25 in the journal Cancer Therapy.

27 Nov 2007

Clinical trials and medical care: Defining the therapeutic misconception

Some research participants do not appreciate important differences between medical research and treatment, says a team of researchers in a policy paper in this week's PLoS Medicine.

27 Nov 2007

$Factors identified to predict hip fracture in postmenopausal women$

Factors identified to predict hip fracture in postmenopausal women

A clinical model that includes 11 factors has been developed to help predict the 5-year risk of hip fracture in postmenopausal women, according to a study in the November 28 issue of JAMA.

27 Nov 2007

$Model provides risk factors for hip fractures in older women$

Model provides risk factors for hip fractures in older women

Experts say there are around 329,000 hip fractures in postmenopausal women in the United States each year and up to 24% of hip fracture patients over 50 die within one year of the injury because of complications related to the injury itself or the extended recovery period.

27 Nov 2007

Wyeth receives European approval for TORISEL

Wyeth Pharmaceuticals, a division of Wyeth, has announced that the European Commission has approved TORISEL (temsirolimus) for the first-line treatment of patients with advanced renal cell carcinoma (RCC) who have at least three of six prognostic risk factors. TORISEL is the only approved cancer therapy that specifically inhibits the mTOR (mammalian target of rapamycin) kinase, an important regulator of cell proliferation, cell growth and cell survival.

27 Nov 2007

New program finds safer ways for college students to cope with alcohol

Researchers from the University of Cincinnati are reporting on a pilot program aimed at curbing alcohol abuse among college students.

27 Nov 2007

FDA accepts Schering-Plough's new drug application for Asenapine

Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) recently accepted the filing for review of the New Drug Application (NDA) for asenapine, a fast-dissolving, sublingual tablet.

26 Nov 2007

Non-Caucasians at higher risk for severe metastatic breast cancer pain

A new study finds significant racial differences in the risk of pain related to metastatic breast cancer.

26 Nov 2007

Major clinical trial of osteoporosis screening begins

Researchers are looking for local women in the Weston/North Somerset area over the age of 70 to take part in the second phase of a major clinical trial to find out if screening older women for osteoporosis can help to reduce the numbers who suffer bone fractures.

26 Nov 2007

Potential link between congenital heart anomaly and migraines

Interventional cardiologists at Rush University Medical Centerare investigating whether a heart procedure may be the key to relieving migraines in patients with severe headaches.

21 Nov 2007

FDA clears Veridex test for the monitoring of metastatic colorectal cancer

Veridex, LLC has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch System to be used as an aid in the monitoring of metastatic colorectal cancer.

21 Nov 2007

Affiris GmbH granted a Europe-wide patent for key elements of its Alzheimer's vaccine

As a result, the company has exclusive rights of use to the peptide sequences for an innovative approach to vaccine development. The tolerability of the first Affiris vaccine, AFFITOPE AD01, is currently being tested as part of a phase I clinical trial. The lead investor in the company, MIG-Fonds, is extremely satisfied with the expanding patent portfolio of Affiris GmbH.

21 Nov 2007

Dyslexia expert Dr. Bruce McCandliss awarded Presidential honor

Dr. Bruce McCandliss, a psychologist at the Sackler Institute for Developmental Psychobiology and associate professor of psychology in psychiatry at Weill Cornell Medical College, has received a commendation by the President of the United States in the form of a Presidential Early Career Award for Scientists and Engineers (PECASE).

20 Nov 2007

Tonsillectomy may increase costs without benefits in some children

A Dutch study suggests that among children with mild or moderate symptoms of throat infections, surgery to remove the tonsils may be more expensive but not necessarily more beneficial than watchful waiting, according to a report in the November issue of Archives of Otolaryngology-Head & Neck Surgery.

20 Nov 2007

Gene-transfer technique trial for childhood blindness under way

Three decades have passed since gene therapy pioneer William W. Hauswirth, Ph.D., and his colleagues at the University of Florida began work on a virus that could safely deliver corrective genes into living animals.

19 Nov 2007

U.S. approval of Nexavar (sorafenib) for inoperable liver cancer

The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.

19 Nov 2007

NewYork-Presbyterian/Weill Cornell opens new section of general surgery called Gastrointestinal Metabolic Surgery

Opening the doors to one of the first academic medical program dedicated to surgical treatment of type 2 diabetes, NewYork-Presbyterian Hospital/Weill Cornell Medical Center has created a new section of General Surgery called Gastrointestinal Metabolic Surgery.

19 Nov 2007

MIT researchers devised novel way to create tiny colonies of living human liver cells that model full-sized organs

Liver toxicity is one of the main reasons pharmaceutical companies pull drugs off the market. These dangerous drugs slip through approval processes due in part to the shortcomings of liver toxicity tests. Existing tests rely on liver cells from rats, which do not always respond to toxins the way human cells do. Or they rely on dying human cells that survive for only a few days in the lab.

19 Nov 2007

Block buster cancer drug Avastin gives hope to brain tumor victims

According to a new study the blockbuster cancer drug Avastin has shown promising results in treating brain cancer victims.

19 Nov 2007

How inhibitor-of-apoptosis chemicals kill tumors

Chemical compounds specially designed to neutralize proteins that would otherwise allow tumor cells to cheat death have been recognized for some time by scientists as a promising new avenue for cancer therapy.

16 Nov 2007